CliffBio
biologic

Flebogamma 5%, Flebogamma 5% Dif

Immune Globulin Intravenous (Human)

Loss of exclusivityDecember 2018projected — 12-year biologic exclusivity estimate
CompanyInstituto Grifols, S.A.

Drug detail

Brand nameFlebogamma 5%, Flebogamma 5% Dif
Active ingredientImmune Globulin Intravenous (Human)
Strength20G/400ML
Dosage formInjection
RouteIntravenous
ModalityBiologic
FDA approvalDecember 2006
Marketing statusRx

More from Instituto Grifols, S.A.

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Flebogamma 5%, Flebogamma 5% Dif patent cliff — loss of exclusivity December 2018 | CliffBio